The Mega Lab serves as the operational hub of Al Mokhtabar’s nationwide network, which comprises more than 460 branches and provides services to approximately five million patients annually through laboratory facilities and home visits.
The latest investment represents the next phase in the long-term development of the Kemnath site, which plays a significant role in the company’s manufacturing operations.
The collaboration integrates Cercare Medical Neurosuite (CMN), a vendor-neutral imaging platform that provides automated perfusion analysis across CT, MRI, and Cone-Beam CT, with Siemens Healthineers’ Syngo DynaCT Multiphase system.
The solution integrates Syngo.CT Coronary Cockpit on the Syngo.via platform with Syngo PCI Connect running on Artis angiography systems.
The company will present its newly CE-marked AI contouring solution at the annual congress of the European Society for Radiotherapy and Oncology in Stockholm.
Photon Flash radiotherapy delivers radiation more than 100 times faster than conventional radiotherapy techniques, to reduce damage to surrounding healthy tissue while effectively targeting tumors.
Results confirmed that Caas vFFR is a safe and effective alternative to conventional pressure wire-based physiology for guiding treatment decisions in patients with intermediate coronary artery stenosis.
The company showcased three new angiography platforms—Artis genio, Artis icono.explore, and Artis icono.vision—which harness artificial intelligence to enhance the precision of liver cancer embolization treatments.
Visitors will explore the latest advancements to improve patient outcomes and operational efficiency through integrated clinical pathways that demonstrate a connected approach from early detection through treatment.
The new Irish facility aims to accelerate innovation and bring next-generation diagnostic capabilities to hospitals and laboratories worldwide.